SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - PHARMACYTE BIOTECH INC ownership

PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q1 2022$80,000
-28.6%
34,805
-22.6%
0.00%
-33.3%
Q4 2021$112,000
-29.1%
44,944
-9.6%
0.00%0.0%
Q3 2021$158,00049,7000.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,061,411$2,378,0001.62%
Ayrton Capital LLC 153,130$343,0000.56%
Shay Capital LLC 982,698$2,201,0000.44%
EQUITEC PROPRIETARY MARKETS, LLC 342,994$768,0000.22%
FNY Investment Advisers, LLC 15,290$34,0000.02%
K2 PRINCIPAL FUND, L.P. 91,095$204,0000.02%
Schonfeld Strategic Advisors LLC 26,200$59,0000.00%
Aspire Private Capital, LLC 800$2,0000.00%
OSAIC HOLDINGS, INC. 1,758$3,0000.00%
BANK OF AMERICA CORP /DE/ 1,734$4,0000.00%
View complete list of PHARMACYTE BIOTECH INC shareholders